Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (51-60 of 466) with videos related to

Pageof 47
Sort By:
Current Opinion in HIV and AIDS|September 8, 2011
Future of hepatitis C therapy: development of direct-acting antiviralsGregory J Dore, Gail V Matthews, Jürgen Rockstroh
Journal of Hepatology|January 3, 2018
Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?"Maryam Alavi, Matthew G Law, Gregory J Dore
The Lancet. Gastroenterology & Hepatology|October 2, 2020
Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confoundingGregory J Dore, Mark Danta, Gail V Matthews
Journal of Hepatology|July 23, 2008
The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposureGail V Matthews, Jason Grebely, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Treatment for hepatitis C virus infection among current injection drug users in AustraliaGail Matthews, Ian J Kronborg, Gregory J Dore
Drug and Alcohol Review|May 23, 2012
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugsCarla Treloar, Peter Hull, Gregory J Dore, et al.
Journal of Gastroenterology and Hepatology|December 17, 2003
Quality of life of women living with hepatitis CHla-Hla Thein, Paul S Haber, Gregory J Dore
Drug and Alcohol Review|November 26, 2009
Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a reviewLibby Topp, Carolyn Day, Gregory J Dore, et al.
Drug and Alcohol Dependence|October 28, 2006
Referral for chronic hepatitis C treatment from a drug dependency treatment settingRichard Hallinan, Andrew Byrne, Kingsley Agho, et al.
Journal of Gastroenterology and Hepatology|June 16, 2005
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Pageof 47

Showing results (51-60 of 466) with videos related to

Sort By:
Pageof 47
Current Opinion in HIV and AIDS|September 8, 2011
Future of hepatitis C therapy: development of direct-acting antiviralsGregory J Dore, Gail V Matthews, Jürgen Rockstroh
Journal of Hepatology|January 3, 2018
Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?"Maryam Alavi, Matthew G Law, Gregory J Dore
The Lancet. Gastroenterology & Hepatology|October 2, 2020
Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confoundingGregory J Dore, Mark Danta, Gail V Matthews
Journal of Hepatology|July 23, 2008
The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposureGail V Matthews, Jason Grebely, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Treatment for hepatitis C virus infection among current injection drug users in AustraliaGail Matthews, Ian J Kronborg, Gregory J Dore
Drug and Alcohol Review|May 23, 2012
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugsCarla Treloar, Peter Hull, Gregory J Dore, et al.
Journal of Gastroenterology and Hepatology|December 17, 2003
Quality of life of women living with hepatitis CHla-Hla Thein, Paul S Haber, Gregory J Dore
Drug and Alcohol Review|November 26, 2009
Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a reviewLibby Topp, Carolyn Day, Gregory J Dore, et al.
Drug and Alcohol Dependence|October 28, 2006
Referral for chronic hepatitis C treatment from a drug dependency treatment settingRichard Hallinan, Andrew Byrne, Kingsley Agho, et al.
Journal of Gastroenterology and Hepatology|June 16, 2005
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Pageof 47